leadership
confidence high
sentiment neutral
materiality 0.25
Design Therapeutics appoints Dr. David Shapiro to Board as Class III director
Design Therapeutics, Inc.
- Dr. David Shapiro appointed to Board effective Mar 31, 2026, as Class III director with term through 2027 annual meeting.
- Receives annual cash retainer of $40k for Board service and $5k for Nominating Committee service.
- Received initial option grant of 60k shares (3-year monthly vest) and prorated annual option of 7.5k shares (1-year vest).
- Also appointed to the Nominating and Corporate Governance Committee.